About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Nashville | 285 Studies

Clinical Trials MelanomaNashville

Melanoma Clinical Trials in Nashville

Find 285 clinical trials for melanoma near Nashville, Tennessee. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Nashville

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-285 of 285 trials

CompletedMolecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is MetastaticThis phase II trial studies how well molecularly targeted therapy works in treating patients with melanoma that has spread to other parts of the body.NCT02094872·Scottsdale, Arizona and 7 others CompletedStudy of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaBased on data demonstrating synergy between paclitaxel and mammalian target of rapamycin (mTOR) inhibition, the investigators propose that the addition of everolimus to paclitaxel…NCT01014351·Fort Myers, Florida and 11 others CompletedA Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent MalignanciesThe purpose of this study is to determine the safety and effectiveness of MDX-1106 in patients with certain types of cancer.NCT00730639·Scottsdale, Arizona and 12 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsThe CC-90003-ST -001 trial is a first-in-man, open-label study in subjects with locally-advanced or wide spread cancers to determine if CC-90003 (an oral medication) can be…NCT02313012·Los Angeles, California and 4 others

TerminatedLGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF MelanomaThe primary purpose of the Phase II CLGX818X2102 study is to assess the anti-tumor activity of LGX818 in combination with selected agents.NCT01820364·Nashville, Tennessee and 5 others

PreviousPage 15 of 15

Other Conditions in Nashville

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma